Tyr182

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Tyr182 - DDB1 (human)

Site Information
APTICFVyQDPQGRH SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 62873405

In vivo Characterization
Methods used to characterize site in vivo:	immunoprecipitation ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:	HEK293T (epithelial) ( 1 )

Upstream Regulation
Putative in vivo kinases:	Abl (human) ( 1 )
Treatments:	imatinib ( 1 )

References
1	Gao S, et al. (2017) Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase. J Biol Chem 292, 3683-3691 28087699 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.